Hemab Therapeutics Holdings, Inc. (COAG) Insider Trading Disclosures
Hemab Therapeutics Holdings, Inc. (COAG) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: COAG
CIK: 2114044
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
EY Godkendt Revisionspartnerselskab
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerChristian Johansen
Audit LocationCopenhagen, Denmark
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-25 | 2026-09-24 | 4 | 0001193125-26-402936 | View SEC Doc Filr Page |
| 3 | 2026-09-25 | 2026-09-24 | 3 | 0001193125-26-402904 | View SEC Doc Filr Page |
| 8-K | 2026-09-24 | 2026-09-24 | 8-K | 0001193125-26-401010 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001388325-26-000046 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0000902664-26-003462 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-12 | — | SCHEDULE 13G Filing | 0001562230-26-000124 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001193125-26-344533 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001193125-26-343421 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0002005369-26-000041 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-06 | — | SCHEDULE 13G Filing | 0000315066-26-002021 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-05 | — | SCHEDULE 13G Filing | 0001104659-26-090835 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | 4 Filing | 0001231919-26-000665 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | 4 Filing | 0001231919-26-000521 | View SEC Doc Filr Page |
| 10-Q | 2026-05-21 | 2026-03-31 | 10-Q | 0001193125-26-234386 | View SEC Doc Filr Page |
| 8-K | 2026-05-21 | 2026-05-21 | 8-K | 0001193125-26-233375 | View SEC Doc Filr Page |
| 4 | 2026-05-14 | 2026-05-12 | 4 Filing | 0001231919-26-000495 | View SEC Doc Filr Page |
| 3 | 2026-05-14 | 2026-05-04 | 3 | 0001193125-26-223979 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-11 | — | SCHEDULE 13G Filing | 0001346824-26-000127 | View SEC Doc Filr Page |
| 4 | 2026-05-11 | 2026-05-07 | 4 Filing | 0001231919-26-000475 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-05-11 | — | SCHEDULE 13D Filing | 0001193125-26-216973 | View SEC Doc Filr Page |
| 8-K | 2026-05-11 | 2026-05-08 | 8-K | 0001193125-26-216699 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-08 | — | SCHEDULE 13G Filing | 0001172661-26-001639 | View SEC Doc Filr Page |
| 4 | 2026-05-06 | 2026-05-04 | 4 Filing | 0001231919-26-000457 | View SEC Doc Filr Page |
| 4 | 2026-05-06 | 2026-05-04 | 4 Filing | 0001388325-26-000023 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-01-29 | 4 | 0001193125-26-204048 | View SEC Doc Filr Page |